Information idarucizumab.at (Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals)

Wertung

Letztes Update: 12.04.2016, 17:09 (alle 3 Tage aktualisiert)

IP-Adresse, die die Domain-Hosts: 94.100.253.195. Name idarucizumab.at es bezieht sich auf 12-zeichen-Domains. Fügen Sie Ihre berichte über idarucizumab.at unten in Form von.

Domain-Namen:	idarucizumab.at
Name:	Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals
Beschreibung:	Boehringer Ingelheim ranks among the world's leading pharmaceutical companies, focusing on prescription medicines, consumer health care, chemicals, biopharmaceuticals and animal health.
Stichworte:	pharmaceutical companies, pharmaceutical jobs, Boehringer Ingelheim, Ingleheim, pharma, animal health, consumer health care, R&D, prescription medicines, biopharmaceuticals, journalists, news releases, Annual Press Conference 2006, facts&figures 2005, clinical trials, Corporate responsibility, research, careers, licensing, job seekers, caring culture, CHC, AH, PM, BI
DNS-Server:	ns3.nameshield.net ns2.observatoiredesmarques.fr obs.ns1.fr
Versorger:	AS34086 T-Systems International GmbH
Organisation:	T-Systems International GmbH
Land:	Germany, Bavaria, Munich
Wie viele Zeichen in Domain:	12
IP, die die Domain-Hosts:	94.100.253.195 (alle Seiten auf dieser IP)